HDAC9 and neoplasm: Mechanistically, HDAC inhibitors seem to prevent DNA DSB repair, but show multiple anti-cancer mechanisms that inhibit oncogenes and tumor angiogenesis, and upregulate expression of tumor suppressor genes and the immune system.